Human Nutraceutical Research Unit
Guelph, Ontario, N1G 2W1, Canada
NCT Number: NCT05526937
The objective of this study is to investigate the effect of inclusion of 50% sprouted wheat wholemeal in a bread recipe on the postprandial glycemic and satiety responses, as well as on appetite-related sensations and acceptability of the developed products relative to a product made with a similar unsprouted wheat recipe.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Guelph, Ontario, N1G 2W1, Canada
This study is a randomized crossover trial involving three different bread products. At each study visit, capillary blood glucose will be measured at fasting, and then 15, 30, 45, 60, 90, and 120 minutes following the start of ingestion of the study food. Visual analogue scales will be used to assess appetite and fullness sensations at fasting, and then 30, 60, 90 and 120 minutes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bread portions of 50 gram available carbohydrates.
Time frame: 2 hours
Capillary blood glucose
Time frame: 2 hours
Hunger, Fullness, Desire to Eat and Prospective Food Consumption questions using Visual Analogue Scales (100 mm lines). Answers are measured and scored from 0 (not at all) to 100 (extreme).
University of Guelph
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06654362
Blood Sugar, Body Weight
Yazd, Iran
View Trial DetailsNCT05185960
Blood Sugar
Toronto, Ontario, Canada
View Trial DetailsNCT01855373
Blood Sugar, Endothelial Function
Fort Lauderdale, Florida, United States
View Trial DetailsNCT07448805
Blood Sugar, Critically Ill Intensive Care Unit Patients
Maribor, Slovenia
View Trial Details